FABP4 and neoplasm: Interestingly, PDGFRβ siRNA reduced levels of the adipogenic marker FABP4 in WDLS, but had no effects on FABP4 in ASCs (Fig. 3e), indicating that PDGFRβ may differentially regulate the differentiation of tumor cells versus normal cells.